Strongbridge Biopharma plc SBBP
2.00 +2.00
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2020 · select a line to chart its full history
Income statement
| Fiscal year | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 |
|---|---|---|---|---|---|
| 30.73M | 21.71M | 18.03M | 7.05M | 0 | |
| 28.52M | 17.89M | 14.04M | 5.56M | 0 | |
| -43.16M | -67.09M | -81.92M | -73.74M | -50.73M | |
| -45.08M | -49.45M | 31.85M | -113.48M | -48.60M | |
| -0.78 | -0.91 | 0.69 | -3.11 | -2.27 |
Balance sheet
| Fiscal year | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 |
|---|---|---|---|---|---|
| 87.52M | 57.03M | 122.49M | 57.51M | 66.84M | |
| 121.10M | 117.64M | 170.28M | 103.92M | 137.53M | |
| 55.49M | 45.45M | 57.33M | 115.84M | 70.56M | |
| 17.11M | 0 | 0 | 37.79M | 18.43M | |
| 65.61M | 72.19M | 112.95M | -11.91M | 66.97M |
Cash flow
| Fiscal year | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 |
|---|---|---|---|---|---|
| -38.13M | -44.78M | -84.58M | -45.34M | -31.71M | |
| 21.11M | -20.76M | 134.33M | -7.50M | -3.39M | |
| 47.51M | 87.00K | 15.23M | 43.51M | 50.32M | |
| -10.00K | -74.00K | -326.00K | 0 | 0 | |
| 30.49M | -65.46M | 64.98M | -9.33M | 15.21M |